Literature DB >> 21185899

Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats.

Andrezza Sossai Rodrigues Carvalho1, Laila Brito Torres, Daniele Suzete Persike, Maria José Silva Fernandes, Debora Amado, Maria da Graça Naffah-Mazzacoratti, Esper Abrão Cavalheiro, Alexandre Valotta da Silva.   

Abstract

Recent research data have shown that systemic administration of pyruvate and oxaloacetate causes an increased brain-to-blood glutamate efflux. Since increased release of glutamate during epileptic seizures can lead to excitotoxicity and neuronal cell death, we tested the hypothesis that glutamate scavenging mediated by pyruvate and oxaloacetate systemic administration could have a neuroprotective effect in rats subjected to status epilepticus (SE). SE was induced by a single dose of pilocarpine (350mg/kgi.p.). Thirty minutes after SE onset, a single dose of pyruvate (250mg/kgi.p.), oxaloacetate (1.4mg/kgi.p.), or both substances was administrated. Acute neuronal loss in hippocampal regions CA1 and hilus was quantitatively determined five hours after SE onset, using the optical fractionator method for stereological cell counting. Apoptotic cascade in the hippocampus was also investigated seven days after SE using caspase-1 and -3 activity assays. SE-induced neuronal loss in CA1 was completely prevented in rats treated with pyruvate plus oxaloacetate. The SE-induced caspase-1 activation was significantly reduced when rats were treated with oxaloacetate or pyruvate plus oxaloacetate. The treatment with pyruvate and oxaloacetate caused a neuroprotective effect in rats subjected to pilocarpine-induced SE.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185899     DOI: 10.1016/j.neuint.2010.12.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  10 in total

Review 1.  Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Authors:  Ming Jia; Steve A Noutong Njapo; Vaibhav Rastogi; Vishnumurthy Shushrutha Hedna
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

2.  Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model.

Authors:  Tanya McDonald; Mark P Hodson; Ilya Bederman; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

Review 3.  Extracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.

Authors:  Agzam Zhumadilov; Matthew Boyko; Shaun E Gruenbaum; Evgeny Brotfain; Federico Bilotta; Alexander Zlotnik
Journal:  Expert Rev Neurother       Date:  2015-04-12       Impact factor: 4.618

Review 4.  Glutamate, T cells and multiple sclerosis.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2017-02-24       Impact factor: 3.575

5.  AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus.

Authors:  Isabella Russo; Daniela Bonini; Luca La Via; Sergio Barlati; Alessandro Barbon
Journal:  Neuromolecular Med       Date:  2013-03-15       Impact factor: 3.843

Review 6.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

7.  A unique array of neuroprotective effects of pyruvate in neuropathology.

Authors:  Yuri Zilberter; Olena Gubkina; Anton I Ivanov
Journal:  Front Neurosci       Date:  2015-02-17       Impact factor: 4.677

8.  Functional Metaplasticity of Hippocampal Schaffer Collateral-CA1 Synapses Is Reversed in Chronically Epileptic Rats.

Authors:  Mirko Rehberg; Timo Kirschstein; Xiati Guli; Steffen Müller; Marco Rohde; Denise Franz; Tursonjan Tokay; Rüdiger Köhling
Journal:  Neural Plast       Date:  2017-10-02       Impact factor: 3.599

Review 9.  Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof.

Authors:  Tanya McDonald; Michelle Puchowicz; Karin Borges
Journal:  Front Cell Neurosci       Date:  2018-08-31       Impact factor: 5.505

10.  Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice.

Authors:  Yang Xin; Chen Diling; Yang Jian; Liu Ting; Hu Guoyan; Liang Hualun; Tang Xiaocui; Lai Guoxiao; Shuai Ou; Zheng Chaoqun; Zhao Jun; Xie Yizhen
Journal:  Front Neurol       Date:  2018-06-15       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.